Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Phytotherapy Research : PTR
|
June 2, 2026
Baicalein Sensitizes Radioresistant BT549 and MCF7-R Breast Cancer Cells by Modulating Rac1 Signaling
Zitong Zhao, Zhangyun Li, Quanzhou Peng, et al.
Frontiers in Oncology
|
September 5, 2022
BTN3A3 inhibits the proliferation, migration and invasion of ovarian cancer cells by regulating ERK1/2 phosphorylation
Sihan Chen, Zhangyun Li, Yanyan Wang, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
December 16, 2025
Efficacy of fulvestrant and capecitabine as maintenance therapy in patients with HR +/HER2 - metastatic breast cancer benefited from first-line chemotherapy
Qing Liu, Lingyan Yu, Zhiwen Zeng, et al.
Journal of Cancer
|
June 21, 2021
Prognostic and Therapeutic Significance of BTN3A Proteins in Tumors
Sihan Chen, Zhangyun Li, Wenyi Huang, et al.
Frontiers in Plant Science
|
September 21, 2018
Molecular Evolution of GDP-D-Mannose Epimerase (<i>GME</i>), a Key Gene in Plant Ascorbic Acid Biosynthesis
Junjie Tao, Han Wu, Zhangyun Li, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
March 22, 2023
The ceramide synthase (CERS/LASS) family: Functions involved in cancer progression
Mengmeng Zhang, Zhangyun Li, Yuwei Liu, et al.
Frontiers in Immunology
|
December 31, 2025
Anti-inflammatory effects of natural polysaccharides: molecular mechanisms and nanotherapeutic applications
Jihao Yang, Kai Xiong, Tengzhen Li, et al.
Cellular Signalling
|
October 8, 2023
BTN3A3 inhibits clear cell renal cell carcinoma progression by regulating the ROS/MAPK pathway via interacting with RPS3A
Zhangyun Li, Mengmeng Zhang, Sihan Chen, et al.
Cell Death & Disease
|
August 14, 2019
Aurora-A/ERK1/2/mTOR axis promotes tumor progression in triple-negative breast cancer and dual-targeting Aurora-A/mTOR shows synthetic lethality
Wenfeng Zhang, Ding Xia, Zhangyun Li, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
August 30, 2017
CyclinG1 Amplification Enhances Aurora Kinase Inhibitor-Induced Polyploid Resistance and Inhibition of Bcl-2 Pathway Reverses the Resistance
Wenfeng Zhang, Jie Xu, Dexiang Ji, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Phytotherapy Research : PTR
|
June 2, 2026
Baicalein Sensitizes Radioresistant BT549 and MCF7-R Breast Cancer Cells by Modulating Rac1 Signaling
Zitong Zhao, Zhangyun Li, Quanzhou Peng, et al.
Frontiers in Oncology
|
September 5, 2022
BTN3A3 inhibits the proliferation, migration and invasion of ovarian cancer cells by regulating ERK1/2 phosphorylation
Sihan Chen, Zhangyun Li, Yanyan Wang, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
December 16, 2025
Efficacy of fulvestrant and capecitabine as maintenance therapy in patients with HR +/HER2 - metastatic breast cancer benefited from first-line chemotherapy
Qing Liu, Lingyan Yu, Zhiwen Zeng, et al.
Journal of Cancer
|
June 21, 2021
Prognostic and Therapeutic Significance of BTN3A Proteins in Tumors
Sihan Chen, Zhangyun Li, Wenyi Huang, et al.
Frontiers in Plant Science
|
September 21, 2018
Molecular Evolution of GDP-D-Mannose Epimerase (<i>GME</i>), a Key Gene in Plant Ascorbic Acid Biosynthesis
Junjie Tao, Han Wu, Zhangyun Li, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
March 22, 2023
The ceramide synthase (CERS/LASS) family: Functions involved in cancer progression
Mengmeng Zhang, Zhangyun Li, Yuwei Liu, et al.
Frontiers in Immunology
|
December 31, 2025
Anti-inflammatory effects of natural polysaccharides: molecular mechanisms and nanotherapeutic applications
Jihao Yang, Kai Xiong, Tengzhen Li, et al.
Cellular Signalling
|
October 8, 2023
BTN3A3 inhibits clear cell renal cell carcinoma progression by regulating the ROS/MAPK pathway via interacting with RPS3A
Zhangyun Li, Mengmeng Zhang, Sihan Chen, et al.
Cell Death & Disease
|
August 14, 2019
Aurora-A/ERK1/2/mTOR axis promotes tumor progression in triple-negative breast cancer and dual-targeting Aurora-A/mTOR shows synthetic lethality
Wenfeng Zhang, Ding Xia, Zhangyun Li, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
August 30, 2017
CyclinG1 Amplification Enhances Aurora Kinase Inhibitor-Induced Polyploid Resistance and Inhibition of Bcl-2 Pathway Reverses the Resistance
Wenfeng Zhang, Jie Xu, Dexiang Ji, et al.
Page
of 2